Evidence map›Paper›PMID 30770800›Full record

ArticleCell death & disease2019

Tryptophan-kynurenine pathway attenuates β-catenin-dependent pro-parasitic role of STING-TICAM2-IRF3-IDO1 signalosome in Toxoplasma gondii infection.

Tanmay Majumdar, Shagun Sharma, Manmohan Kumar, Md Arafat Hussain, Namita Chauhan, Inderjeet Kalia, Amit Kumar Sahu, Vipin Singh Rana, Ruchi Bharti, Arun Kumar Haldar and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Prevalence ofMicroorganisms · 2024
    Article
  8. Article
  9. iScience · 2023
    Article
  10. Article
  11. Article
  12. ExploringFrontiers in cellular and infection microbiology · 2023
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Modulation of autophagy as a therapeutic strategy forFrontiers in cellular and infection microbiology · 2022
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Tanmay MajumdarImmunobiology Laboratory, Department of Zoology, University of Delhi, Delhi, 110007, India. majumdartanmay@gmail.com.
Shagun SharmaImmunobiology Laboratory, Department of Zoology, University of Delhi, Delhi, 110007, India.
Manmohan KumarImmunobiology Laboratory, Department of Zoology, University of Delhi, Delhi, 110007, India.
Md Arafat HussainImmunobiology Laboratory, Department of Zoology, University of Delhi, Delhi, 110007, India.
Namita ChauhanDepartment of Zoology, University of Delhi, Delhi, 110007, India.
Inderjeet KaliaInfectious Diseases Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, Delhi, 110067, India.
Amit Kumar SahuInfectious Diseases Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, Delhi, 110067, India.
Vipin Singh RanaDepartment of Zoology, University of Delhi, Delhi, 110007, India.
Ruchi BhartiImmunobiology Laboratory, Department of Zoology, University of Delhi, Delhi, 110007, India.
Arun Kumar HaldarDivision of Biochemistry, CSIR-Central Drug Research Institute, Sector-10, Jankipuram Ext., Lucknow, 226031, India.
Agam P SinghInfectious Diseases Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, Delhi, 110067, India.
Shibnath MazumderImmunobiology Laboratory, Department of Zoology, University of Delhi, Delhi, 110007, India.
University of Delhi · INNational Institute of Immunology · INCentral Drug Research Institute · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have documented the diverse role of host immunity in infection by the protozoan parasite, Toxoplasma gondii. However, the contribution of the β-catenin pathway in this process has not been explored. Here, we show that AKT-mediated phosphorylated β-catenin supports T. gondii multiplication which is arrested in the deficiency of its phosphorylation domain at S552 position. The β-catenin-TCF4 protein complex binds to the promoter region of IRF3 gene and initiates its transcription, which was also abrogated in β-catenin knockout cells. TBK-independent phosphorylation of STING(S366) and its adaptor molecule TICAM2 by phospho-AKT(T308S473) augmented downstream IRF3-dependent IDO1 transcription, which was also dependent on β-catenin. But, proteasomal degradation of IDO1 by its tyrosine phosphorylation (at Y115 and Y253) favoured parasite replication. In absence of IDO1, tryptophan was catabolized into melatonin, which supressed cellular reactive oxygen species (ROS) and boosted parasite growth. Conversely, when tyrosine phosphorylation was abolished by phosphosite mutations, IDO1 escaped its ubiquitin-mediated proteasomal degradation system (UPS) and the stable IDO1 prevented parasite replication by kynurenine synthesis. We propose that T. gondii selectively utilizes tryptophan to produce the antioxidant, melatonin, thus prolonging the survival of infected cells through functional AKT and β-catenin activity for better parasite replication. Stable IDO1 in the presence of IFN-γ catabolized tryptophan into kynurenine, promoting cell death by suppressing phospho-AKT and phospho-β-catenin levels, and circumvented parasite replication. Treatment of infected cells with kynurenine or its analogue, teriflunomide suppressed kinase activity of AKT, and phosphorylation of β-catenin triggering caspase-3 dependent apoptosis of infected cells to inhibit parasite growth. Our results demonstrate that β-catenin regulate phosphorylated STING-TICAM2-IRF3-IDO1 signalosome for a cell-intrinsic pro-parasitic role. We propose that the downstream IRF3-IDO1-reliant tryptophan catabolites and their analogues can act as effective immunotherapeutic molecules to control T. gondii replication by impairing the AKT and β-catenin axis.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsApoptosisbeta CateninCaco-2 CellsCrotonatesGene Knockout TechniquesHumansHydroxybutyratesIndoleamine-Pyrrole 2,3,-DioxygenaseInterferon Regulatory Factor-3KynurenineMembrane ProteinsMiceNitrilesPhosphorylationAdaptor Proteins, Signal Transducingbeta CateninCrotonatesCTNNB1 protein, humanHydroxybutyratesIDO1 protein, humanIndoleamine-Pyrrole 2,3,-DioxygenaseInterferon Regulatory Factor-3IRF3 protein, humanKynurenineMembrane ProteinsNitrilesProto-Oncogene Proteins c-aktSTING1 protein, humanSTING ProteinteriflunomideTICAM2 protein, humanToluidinesTryptophan

Identifiers

PMID30770800
PMCPMC6377608
OpenAlexW2912041501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.